Abstract
Objectives
Historically, little was known about the effects of low blood lead level (BLL < 10 μg/dL) on hypertension (HTN). The purpose of this study was to assess the effects of low BLL on blood pressure (BP) and HTN in lead‐exposed male workers in the Republic of Korea.
Methods
From the year 2000 to 2004, 12,060 male workers underwent an Annual Specialised Medical Check‐up for lead; 7,341 subjects had a peak BLL < 10 μg/dL and were selected for the study. The quartiles of peak BLL in lead‐exposed workers were as follows: first (0.01‐3.68 μg/dL), second (3.69‐5.19 μg/dL), third (5.20‐6.86 μg/dL), and fourth (6.87‐10.00 μg/dL). To examine the relationship between BLL and pre‐HTN (systolic BP [SBP] ≥120‐140 mmHg; diastolic BP [DBP] ≥80‐90 mmHg) and between BLL and HTN (SBP ≥ 140 mmHg; DBP ≥ 90 mmHg), the quartiles of BLL were used as independent variables in multiple logistic regression analysis.
Results
In multiple linear regression analyses, SBP (β 0.04, P < .01) and DBP (β 0.06, P < .01) increased in line with a 1 μg/dL increase in BLL. The odds ratio (OR) of HTN in the fourth versus first BLL quartile (1.54; 95% confidence interval [CI]: 1.26, 1.89) was statistically significant.
Conclusion
SBP and DBP were statistically significantly associated with peak BLL. A BLL ≥ 6.87 μg/dL was associated with HTN; thus, even in workers with low BLLs (<10 μg/dL), management of BP is likely to be necessary. Modulation of the current safety standards for BLLs in workers will be needed.
Keywords: blood pressure, hypertension, lead
1. INTRODUCTION
Hypertension (HTN) is a serious health problem that affects approximately one billion people worldwide today.1 In the Republic of Korea, more than 11 million Korean adults are estimated to have HTN.2 The causes of HTN can be divided into genetic and environmental factors. Known environmental factors to date include lifestyle habits such as smoking, drinking and diet, stress, and exposure to harmful heavy metals including cadmium, mercury, and lead.3, 4
Among heavy metals, lead has been suspected to influence blood pressure (BP) and cardiovascular disease for many years.5 Population research on the cardiovascular effects of lead has focused largely on the association with BP or HTN.6 In the second National Health and Nutrition Examination Survey in the United States, a direct relationship was found between blood lead level (BLL) and systolic BP (SBP) and diastolic BP (DBP) in men and women.7 In the 2008‐2013 Korean National Health and Nutrition Examination Survey, an association was found between BLL and the risk of HTN in the general population in Korea.8
A systematic review concluded that long‐term exposure to high levels of lead can cause HTN.6 Some studies also demonstrated a progressive dose‐response relationship between lead exposure and BP.6 However, the shape of the dose‐response relationship has not been completely characterised, particularly at low levels of exposure.6 The question of whether low‐level lead exposure increases BP in the population is still controversial. In 1991, the US Centers for Disease Control and Prevention (CDC) established 10 μg/dL as the lowest level of concern for BLLs in children.9 This value is extremely important because, historically, policy makers and public health officials typically acted to remove sources of lead exposure only after the CDC’s level of concern had been exceeded.10 However, the lowest BLL associated with BP in adults remains unclear, although available studies suggest no evidence of a threshold effect.6
Since 1972, lead‐exposed workers in the Republic of Korea have been required to undergo an Annual Specialised Medical Check‐up (ASMC) under the Industrial Health Safety Act.11 Using ASMC data, we aimed to retrospectively analyze the potential association of BLL (<10 μg/dL) with BP and HTN.
2. METHODS
2.1. Study subjects
Since 2000, ASMC data for exposure to occupational hazards (143 chemicals, 6 types of dust, 8 physical agents, and 19 metals, including lead) have been electronically stored and monitored by the Korean Occupational Safety and Health Agency (KOSHA). The ASMC is conducted at more than 100 medical centers nationwide approved by KOSHA for the evaluation of Korean workers exposed to lead in the form of dust, fumes, etc.11, 12 From 2000 to 2004, all study subjects underwent more than one General Health Check‐up (GHC). The GHC is available to all local householders aged >20 years, including individuals covered by workplace health insurance. For blue‐collar workers, the GHC is required annually and comprises routine questions about medical history, a physical examination, and laboratory tests. The physical examination comprises measurement of the subject's height, weight, SBP, DBP, etc. Laboratory tests comprise an evaluation of overnight fasting blood sugar, lipid profile, total cholesterol (TC), etc.13 A total of 12 060 male workers underwent at least one ASMC for lead, excepting tests for other heavy metals and noise, from January 1, 2000 to December 31, 2004. The ASMC data for these workers were merged into the GHC data during the same period. Among these workers, 7341 (60.9%) with no missing values for mean SBP, DBP, Body Mass Index (BMI), and TC, and whose mean peak BLL was <10 μg/dL during the study period were selected as study subjects.
2.2. Sampling and analysis of blood lead levels
KOSHA conducts a twice‐yearly quality assurance program to monitor the institutes and hospitals that participate in the ASMC.12, 14 These institutes and hospitals should pass an analytical proficiency test for trace metal analysis to continue participating in the ASMC program.12, 14 KOSHA‐Licensed institutes and hospitals collect and analyze blood samples from lead workers as required by the ASMC. Sampling and analysis of BLL are performed in accordance with the South Korean Occupational Safety and Health Administration (KOSHA)‐CODE H‐09‐1998,14, 15 which was developed by KOSHA based on guidelines established by the National Institute for Occupational Safety and Health.14, 16 .
2.3. Measurement of BP, TC, and BMI
The BPs of the examinees were measured after a sufficient rest period before the examination.13 BP was measured using an automatic sphygmomanometer after the subject had maintained 5 minutes of stable condition while sitting.13 If SBP was ≥120 mmHg or DBP was ≥80 mmHg in the first examination, re‐examination was performed after more than 2 minutes.13 If SBP was ≥140 mmHg or DBP was ≥90 mmHg in the first examination, a second examination was performed after 2 weeks. The second examination was performed in the same manner as the first.13 HTN was defined as a mean DBP of at least 90 mmHg or a mean SBP of at least 140 mmHg from January 1, 2000 to December 31, 2004. Pre‐HTN was defined as a mean DBP of at least 80 mmHg (but below 90 mmHg) or a mean SBP of at least 120 mmHg (but below 140 mmHg) during this period.8 The authors could not consider the use of anti HTN drugs in workers to distinguish between normal BP and HTN due to the lack of data. The TC test was performed after fasting for more than 8 hours and TC and BMI (kg/m2) were measured in accordance with the guidelines of the Ministry of Employment and Labor.13 The mean TC and BMI during the study period were used.
2.4. Study ethics
The study protocol was reviewed and approved by the institutional review board of Dongguk University Gyeongju Hospital. Informed Consent Registry and the Registration No. of the study/Trial: 110757‐201602‐HR‐06‐02 (This study met the requirements for exemption from IRB review, which included obtaining informed consent from the subjects).
2.5. Statistical analyses
To assess the differences in pre‐HTN, HTN, SBP, DBP, subjects’ age in the year 2000, TC, and BMI with peak BLL quartile, one‐way analysis of variance and the chi‐squared test were used. To examine the demographics of lead‐exposed male workers, the t test was used (Table 1). To examine the association between BP and BLL (per μg/dL), SBP and DBP for study subjects were regressed against BLLs after adjustment for covariates (Table 2). Odds ratios (ORs) and 95% confidence intervals (CIs) for pre‐HTN and HTN were calculated for the quartiles of BLL: first (0.01‐3.69 μg/dL), second (3.70‐5.19 μg/dL), third (5.20‐6.86 μg/dL), and fourth (6.87‐10.00 μg/dL; Table 3). The covariates were the same for multiple linear regression and logistic regression analyses (age in the year 2000, TC, BMI), which were performed using the R Studio program (version 3.5.2). HTN and pre‐HTN were treated as dichotomous variables, with DBP and SBP as continuous variables.
Table 1.
Demographic of male lead exposed wokres (n = 7,341) in South Korea
| Variables | n (%) or mean ± SD |
|---|---|
| Age in 2000 (y) | |
| <20 | 373 (5.1) |
| 20‐30 | 3,493 (47.6) |
| 30‐40 | 2,271 (30.9) |
| 40‐50 | 975 (13.3) |
| >50 | 29 (3.1) |
| Age in 2000 (y) | 31.1 ± 0.8.5 |
| Blood pressure | |
| Normal | 2,489 (33.9) |
| Prehypertension | 3,950 (53.8) |
| Hypertension | 902 (12.3) |
| Systolic blood presssure (mmHg) | 121.4 ± 12.6 |
| Diatolic blood pressure (mmHg) | 76.5 ± 9.2 |
| Peaklead (ug/dL) | 5.3 ± 0.2.2 |
| Body mass index | 22.6 ± 0.3.0 |
| Total cholesterol (㎎/dL) | 177.8 ± 34.1 |
Table 2.
Characteristics of lead‐ exposed workers in South Korea by quartiles of (Q1–Q4) of lead in blood
| Quartile of blood lead level | 1st | 2nd | 3rd | 4th | P‐value | Total |
|---|---|---|---|---|---|---|
| Range | 0.01‐3.68 | 3.69‐5.19 | 5.20‐6.86 | 6.87‐10.00 | 0‐10.0 | |
| n | 1,839 | 1,849 | 1,820 | 1,833 | 7,341 | |
| Blood pressure | ||||||
| Normal | 651 (35.4) | 650 (35.2) | 625 (34.3) | 563 (30.7) | <.01 | 2,489 (33.9) |
| Prehypertension | 1,010 (54.9) | 1,006 (54.4) | 963 (52.9) | 971 (53.0) | <.01 | 3,950 (53.8) |
| Hypertension | 178 (9.7%) | 193 (10.4) | 232 (12.7) | 299 (16.3) | <.01 | 902 (12.3) |
| Age in 2000 | 28.9 ± 7.7 | 30.3±0.8.1 | 32.0 ± 8.8 | 33.0 ± 8.9 | <.01 | 31.0 ± 8.5 |
| Total cholesterol (mg/dL) | 175.7 ± 32.0 | 176.5 ± 32.9 | 178.9 ± 37.3 | 180.1 ± 33.4 | <.01 | 177.8 ± 33.9 |
| Body mass index | 22.7 ± 3.0 | 22.7 ± 2.9 | 22.8 ± 3.0 | 23.0 ± 3.0 | <.01 | 22.8 ± 3.0 |
Table 3.
The beta and differences (95% CIs) in systolic blood pressure and diastolic blood pressure by blood lead quartile in lead exposed workers in South Korea
| B | β | S.E. | t | P‐value | |
|---|---|---|---|---|---|
| SBPa | |||||
| Per BLL lug/dLa | 0.24 | 0.04 | 0.09 | 2.55 | .01 |
| DBPa | |||||
| Per BLL lug/dLa | 0.35 | 0.06 | 0.06 | 5.45 | <.01 |
Abbreviations: BLL; blood lead level; DBP, diastolic blood pressure; SBP, systolic blood pressure.
Adjusted by age in 2000, total cholesterol, body mass index (all are continuous variables).
3. RESULTS
3.1. Demographic of study subjects
The mean age of the study subjects in the year 2000 (n = 7341) was 31.1 ± 8.5 years and most of them were in their 20s and 30s (78.5%). Their mean SBP was 121.4 ± 12.6 mmHg, DBP was 76.5 ± 9.2 mmHg, and peak lead was 5.3 ± 2.2 μg/dL. Their mean BMI was 22.6 ± 3.0 and TC was 177.8 ± 34.1 mg/dL (Table 1).
3.2. Characteristics of lead‐exposed workers according to BLL quartile (Q1‐Q4)
SBP, DBP, subject age in the year 2000, TC, and BMI were statistically significantly different according to the BLL quartile (P < .01). The proportions of HTN, age in the year 2000, TC, and BMI increased with the increment of the BLL quartile (Table 2).
3.3. SBP and DBP in lead‐exposed workers according to BLL quartile (Q1‐Q4)
In multiple linear regression analyses, SBP (β 0.04, P = .01) and DBP (β 0.06, P < .01) increased in line with a 1 μg/dL increase in BLL (Table 3).
3.4. Pre‐HTN and HTN in lead‐exposed workers according to BLL quartile (Q1‐Q4)
The OR of HTN was statistically significantly higher for the fourth versus the first BLL quartile (OR 1.54; 95% CI: 1.26, 1.89) (Table 4).
Table 4.
The association with blood lead quartiles and prehypertension and hypertension in lead exposed workers in South Korea
| OR | 95% CI | P‐value | |
|---|---|---|---|
| Pre hypertension | |||
| Lead 1sta | 1 | ||
| Lead 2nda | 1.01 | 0.87‐1.16 | .93 |
| Lead 3tha | 1.00 | 0.87‐1.16 | .97 |
| Lead 4tha | 1.12 | 0.97‐1.30 | .13 |
| Hypertension | |||
| Lead 1sta | 1 | ||
| Lead 2nda | 1.04 | 0.83‐1.29 | .74 |
| Lead 3rda | 1.20 | 0.97‐1.48 | .10 |
| Lead 4tha | 1.54 | 1.26‐1.89 | <.01 |
Adjusted by age in 2000, total cholesterol, body mass index (all are continuous variables).
4. DISCUSSION
Most previous studies targeted individuals exposed to high lead levels.5, 6 Therefore, our study is meaningful in that it assesses the relationship between occupational exposure to low lead levels and BP. Our study showed that SBP and DBP increased with each 1 μg/dL increment in BLL, and the OR of HTN increased as the BLL quartile increased. The relationship between SBP, DBP, and BLL was examined with multiple linear and logistic regression analysis. A significant link between BLL, SBP, and DBP was found. In addition, an association between BLL and HTN was observed, supported by statistically significant ORs after adjusting for covariates such as subject age in the year 2000, TC and BMI, These findings are compatible with those of previous studies, which concluded that exposure to lead causes BP elevation.5, 6 BLL is generally used as an indicator of recent exposure to lead, since the half‐life of lead in blood is approximately 1 month;17 bone lead level reflects cumulative exposure. The peak lead level in our study agreed with that in another study, which concluded that bone lead level was positively associated with increased SBP.18, 19
Many researchers have reported a relationship between lead exposure and cardiovascular disease.5, 6, 15 BP elevation due to lead exposure has also been observed in cross‐sectional, cohort, and experimental studies.5, 6, 20, 21 A systematic review concluded that long‐term exposure to high levels of lead can cause HTN.6 However, the question of whether low‐level lead exposure causes increased BP in the population remains controversial because the causal nature of the correlation has not been proven.22, 23 The published literature suggests only a weak, positive relationship between BP and BLL.24 A previous meta‐analysis indicated that a doubling of BLL was associated with a 1.0‐mmHg rise in SBP and a 0.6‐mmHg rise in DBP.6, 24 However, the association was not consistently supported by previous studies of BLL and BP.25, 26 For instance, one study of environmental lead exposure evaluated the relationship between BLL and BP in local residents living near a copper smelter in the Republic of Korea: no correlation between BLL and BP was observed.26
The precise mechanisms underlying the hypertensive effect of chronic low exposure to environmental lead are unknown.6 Conversely, the development of HTN in subjects chronically exposed to high lead levels has been attributed to lead nephropathy.6, 27, 28 An inverse association between estimated glomerular filtration rate and BLL has been observed at BLLs below 5 μg/dL in the general population.27 Changes in the renin‐angiotensin system and malfunctions in sodium handling lead to toxic effects after exposure to low lead concentrations.29 Lead exposure causes oxidative stress, which reduces nitric oxide availability, increases systemic vascular resistance,30, 31 and alters the activity and production of the hormones that control vascular tone.32
This study has several limitations. First, data about antihypertensive drug use and a family history of HTN, which could be important confounders, were limited because the secondary data were collected via GHC. However, hypertensive heredity and BP elevations after lead exposure were not significantly related in one study,31 in which the authors indicated that a study such as ours would be appropriate. Second, our study lacked lead‐exposure data for workers before the formation of the study cohort.
Data about the total burden of lead exposure during a worker's lifetime are generally limited; however, some lead‐exposed workers may quit their jobs because of lead‐related or renal disease.21 Finally, the BP‐elevating role of lead could be due to other environmental risk factors such as alcohol intake or smoking habit,33 social economic status,34 salt and potassium intake, physical activity, and psychosocial stress.35 Indeed, Garndjean et al36 showed a significant relationship between alcohol intake and BLL and BP. In our study, information about alcohol intake and smoking habit was not available due to the limited amount of secondary data collected. Further studies are needed that include lifestyle factors, social economic status, employment type, work duration, family history of HTN, and antihypertensive drug use in employees.
Despite these limitations, our study has some important implications. First, all cohort members occupationally exposed to lead were consistently assessed at least once, so that data for up to 5 years were available to determine the median BP and mean values of BMI, TC, and peak BLL. Many previous studies performed single measurements to evaluate lead exposure,6 which may have caused BLL and BP measurement errors. However, the possibility of underestimation was reduced in our study due to continuous measurement of BLL and BP for 5 years. Second, ASMC recipients exposed to other metals, and therefore potential confounders, were excluded so that any relationship between lead exposure and BP could be identified more clearly. Furthermore, the use of special medical check‐up data allowed for a large sample size and a large retrospective cohort with occupational exposure to low levels of lead, relative to previous similar studies.
5. CONCLUSIONS
In conclusion, a BLL >6.87 μg/dL was associated with HTN in Korean men occupationally exposed to lead. Lower levels of lead in blood than the current occupational safety standards were shown to elevate BP in our study. The substantial evidence that chronic lead exposure affects cognitive function and renal function at levels <5 μg/dL indicate that the US Centers for Disease Control and Prevention criterion for elevated blood levels in children (10 μg/dL) is too high for adults.6, 27, 37 Consequently, modulation of the current safety standards established by the Korean Ministry of Employment and Labor and the US Occupational Safety and Health Administration for BLLs in workers (currently established at 30 μg/dL and 40 μg/dL, respectively) is needed.38, 39 To establish a new reference BLL, long‐term accumulation of data and large‐sized samples of workers with low BLLs are required through further study. Furthermore, considering the effects of lead on cardiovascular disease including HTN, regulatory and public health interventions should be developed to prevent and reduce lead exposure. A criterion for elevated blood lead levels in adults needs to be established and screened for in preventive services.6 For workers with low BLLs (ie below current biological‐exposure indices), additional efforts are needed to decrease lead exposure in the workplace, monitor BP, and prevent serious cardiovascular health problems due to HTN.
DISCLOSURE
Approval of the research protocol: This study was reviewed by the Institutional Review Board (IRB) of Dongguk University of Gyeongju Hospital. Informed consent: N/A (This study met the requirements for exemption from IRB review, which included obtaining informed consent from the subjects.). Animal studies: Not included. Registry and the registration no. of the study/trial: 110757‐201602‐HR‐06‐02. Conflict of interest: The authors declare that they have no conflicts of interest.
AUTHOR CONTRIBUTIONS
YSA and MGK conceived the study idea; YSA collected the data; MGK and YSA analyzed the data; and MGK and YWK led the writing.
Kim MG, Kim YW, Ahn Y‐S. Does low lead exposure affect blood pressure and hypertension?. J Occup Health. 2020;62:e12107 10.1002/1348-9585.12107
REFERENCES
- 1. Chobanian AV, Bakris GL, Black HR, et al.; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee . The seventh report of the joint national committee on prevention detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560‐2572. [DOI] [PubMed] [Google Scholar]
- 2. The Korean Society Hypertension (KSH), Hypertension Epidemiology Research Working Group , Kim HC, Cho M‐C. Korea hypertension fact sheet 2018. Clin Hypertens. 2018;24:13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Valera B, Muckle G, Poirier P, Jacobson SW, Jacobson JL, Dewailly E. Cardiac autonomic activity and blood pressure among Inuit children exposed to mercury. Neurotoxicology. 2012;33(5):1067‐1074. [DOI] [PubMed] [Google Scholar]
- 4. Hong D, Cho SH, Park SJ, Kim SY, Park SB. Hair mercury level in smokers and its influence on blood pressure and lipid metabolism. Environ Toxicol Pharmacol. 2013;36(1):103‐107. [DOI] [PubMed] [Google Scholar]
- 5. Goyer RA. Lead toxicity: current concerns. Environ Health Perspect. 1993;100:177‐187. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Navas‐Acien A, Guallar E, Silbergeld EK, Rothenberg SJ. Lead exposure and cardiovascular disease–a systematic review. Environ Health Perspect. 2007;115(3):472‐482. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Harlan WR, Landis JR, Schmouder RL, Goldstein NG, Harlan LCJAMA. Blood lead and blood pressure. Relationship in the adolescent and adult. US population. 1985;253(4):530‐534. [DOI] [PubMed] [Google Scholar]
- 8. Lee BK, Ahn J, Kim NS, Lee CB, Park J, Kim Y. Association of blood pressure with exposure to lead and cadmium: analysis of data from the 2008–2013 Korean national health and nutrition examination survey. Biol Trace Elem Res. 2016;174(1):40‐51. [DOI] [PubMed] [Google Scholar]
- 9. CDC . Preventing lead poisoning in young children. Atlanta, GA: US department of health and Human Services; 1991. [Google Scholar]
- 10. Gilbert SG, Weiss B. A rationale for lowering the blood lead action level from 10 to 2 microg/dL. Neurotoxicology. 2006;27(5):693‐701. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Korean Ministry of Labor (KMOL) . 2003 Workers Health Surveillance Results. Seoul: KMOL, 2004. (in Korea). [Google Scholar]
- 12. Korean Ministry of Labor (KMOL) . Quality Assurance Standard for Special Health Surveillance. KMOL Notification 2004–17. (In Korean).
- 13. Korea Ministry of Employment and Labor . Standard for health examination. [Asterisk 1] General health examination; examination items, examination costs, subjects and methods of examination [Internet]. 2019 Accessed October 30, 2019. http://www.law.go.kr/LSW//admRulLsInfoP.do?admRulSeq=2100000174049
- 14. Kim KR, Lee SW, Paik NW, Choi KG. Low‐level lead exposure among South Korean lead workers, and estimates of associated risk of cardiovascular disease. J Occupat Environ Hyg. 2008;5(6). [DOI] [PubMed] [Google Scholar]
- 15. Korean Occupational Safety and Health Administration (KOSHA) . An analytical guidance of biomarkers for Lead KOSHA CODE H‐09‐1998. Incheon, South Korea: KOSHA, 1998. (In Korean) [Google Scholar]
- 16. National Institute for Occupational Safety and Health (NIOSH) . 1994. Method 7105 LEAD by GFAAS and 7082 LEAD by FAAS In: Schlecht PC, O'Connor PF, eds. NIOSH Manual of Analytical Methods (NMAM) DHHS (NIOSH) Pub. no. 94‐113, 4th ed Cincinnati, OH: NIOSH. [Google Scholar]
- 17. United Nations Environment Programme, International Labour Organisation, and World Health Organization . International Program on Chemical Safety (IPCS): Inorganic Lead [IPCS INCHEM Web site]. Geneva, Switzerland: World Health Organization; 1995. http://www.inchem.org/documents/ehc/ehc/ehc165.htm. Accessed December 16, 2019 [Google Scholar]
- 18. Hu H, Shih R, Rothenberg S, Schwartz BS. The epidemiology of lead toxicity in adults: measuring dose and consideration of other methodologic issues. Environ Health Perspect. 2007;115:455‐462. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Cheng Y, Schwartz J, Sparrow D, Aro A, Weiss ST, Hu H. Bone lead and blood lead levels in relation to baseline blood pressure and the prospective development of hypertension: the Normative Aging Study. Am J Epidemiol. 2001;153:164‐171. [DOI] [PubMed] [Google Scholar]
- 20. Glenn BS, Stewart WF, Links JM, Todd AC, Schwartz BS. The longitudinal association of lead with blood pressure. Epidemiology. 2003;14:30‐36. [DOI] [PubMed] [Google Scholar]
- 21. Wu T‐N, Shen C‐Y, Ko K‐N, et al. Occupational lead exposure and blood pressure. Int J Epidemiol. 1996;25(4):791‐796. [DOI] [PubMed] [Google Scholar]
- 22. Dolenc P, Staessen JA, Lauwerys RR, Amery A. On behalf of the Cadmibel Study Group . Low level exposure to lead does not increase blood pressure in the population at large. J Hypertens. 1993;11:589‐593. [DOI] [PubMed] [Google Scholar]
- 23. Staessen A, Dolenc P, Amery A, et al. On behalf of the Cadmibel Study Group . Environmental lead exposure does not increase blood pressure in the population at large: evidence from the Cadmibel Study. J Hypertens. 1993;11(suppl 2):S35‐S41. [DOI] [PubMed] [Google Scholar]
- 24. Staessen JA, Bulpitt CJ, Fagard R, et al. Hypertension caused by low‐level lead exposure: myth or fact? J Cardiovasc Risk. 1994;1:87‐97. [PubMed] [Google Scholar]
- 25. Sw P, Kim DH. The relationship of low level blood lead to plasma renin activity and blood pressure. Korean J Preve Med. 1991;24:516‐530. [Google Scholar]
- 26. Eom S‐Y, Yim D‐H, Moon S‐I, et al. The association of blood concentrations of healvy metals and blood pressure in residents living near Janghang copper smelter in Korea. J Agri Med Com Health. 2017;42(1):13‐23. [Google Scholar]
- 27. Ekong EB, Jaar BG, Weaver VM. Lead‐related nephrotocixity a review of the epidemiologic evidence. Kidney Int. 2006;70:2074‐2084. [DOI] [PubMed] [Google Scholar]
- 28. Muntner P, Menke A, DeSalvo KB, Rabito FA, Batuman V. Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys. Arch Intern Med. 2005;165:2155‐2161. [DOI] [PubMed] [Google Scholar]
- 29. Fleischer N, Mouw R, Vander AJ. Chronic effects of lead on renin and renal sodium excretion. J Lab Clin Med. 1980;95:759‐770. [PubMed] [Google Scholar]
- 30. Stohs SJ, Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med. 1995;18:321‐336. [DOI] [PubMed] [Google Scholar]
- 31. Vaziri ND, Ding Y, Ni Z. Compensatory up‐regulation of nitric‐oxide synthase isoforms in lead‐induced hypertension;reversal by a superoxide dismutase‐mimetic drug. J Pharmacol Exp Ther. 2001;298:679‐685. [PubMed] [Google Scholar]
- 32. Vaziri ND. Mechanisms of lead‐induced hypertension and cardiovascular disease. Am J Physiol Heart Circ Physiol. 2008;295:454‐465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Rapisarda V, Ledda C, Ferrante M, et al. Blood pressure and occupational exposure to noise and lead (Pb): a cross‐sectional study. Toxicol Ind Health. 2015;pii:0748233715576616. [DOI] [PubMed] [Google Scholar]
- 34. Leng B, Jin Y, Li G, Chen L, Jin L. Socioeconomic status and hypertension; a meta‐ analysis. Hypertens. 2015;33(2):221‐229. [DOI] [PubMed] [Google Scholar]
- 35. Perry IJ, Whincup PH, Shaper AG. Environmental factors in the development of essential hypertension. Br Med Bull. 1994;50(2):246‐259. [DOI] [PubMed] [Google Scholar]
- 36. Grandjean P, Hollnagel H, Hedegaard L, Christensen JM, Larsen S. Blood lead‐blood pressure relations: alcohol intake and hemoglobin as confounders. Am J Epidemiol. 1989;129(4):732‐739. [DOI] [PubMed] [Google Scholar]
- 37. Shin RA, Hu H, Weisskopf MG, Schwartz BS. Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead. Environ Health Perspect. 2007;115:483‐492. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Korea Occupational Safety and Health Occupational Safety and Health Research Institute . Practical guide line for workers’ health check‐up In: KMG , eds. Vol. 2, Special Health Check‐up for Harmful factors. Ulasn, South Korea: Korea Occupational Safety and Health; 2018:221‐223 (In Korea). [Google Scholar]
- 39. U.S. Department of Labor, Occupational Safety and Health Administration . Lead standard, 29 CFR Part1910.1025, Washington DC, US Government Printing Office; 1990s. [Google Scholar]
